Published in J Thorac Oncol on May 01, 2008
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Evaluation of lymph node metastasis in lung cancer: who is the chief justice? J Thorac Dis (2015) 0.77
Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell (2003) 4.27
CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol (2006) 3.39
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol (2008) 3.27
Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol (2005) 2.87
Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study. Lancet Oncol (2013) 2.34
Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol (2002) 2.18
Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol (2006) 2.11
A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol (2008) 2.01
Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience. J Thorac Oncol (2010) 1.96
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol (2006) 1.88
Aortic regurgitation after valve-sparing aortic root replacement: modes of failure. Ann Thorac Surg (2011) 1.85
Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer (2003) 1.82
Focal ground-glass opacity detected by low-dose helical CT. Chest (2002) 1.79
Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg (2010) 1.76
Green light drives leaf photosynthesis more efficiently than red light in strong white light: revisiting the enigmatic question of why leaves are green. Plant Cell Physiol (2009) 1.75
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol (2010) 1.73
Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study. J Neurol Sci (2011) 1.73
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. Cancer Sci (2010) 1.72
Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci (2007) 1.67
Retracted NF-kappaB activation by Helicobacter pylori requires Akt-mediated phosphorylation of p65. BMC Microbiol (2009) 1.59
Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients. Int J Clin Oncol (2006) 1.55
Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS. Intern Med (2005) 1.54
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol (2011) 1.53
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. J Thorac Oncol (2008) 1.53
Pulmonary angioplastic procedure for lung cancer surgery. Gen Thorac Cardiovasc Surg (2010) 1.51
Short and midterm outcomes of elective total aortic arch replacement combined with coronary artery bypass grafting. Ann Thorac Surg (2012) 1.51
Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J (2005) 1.49
Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization. Int J Stroke (2012) 1.49
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One (2011) 1.48
Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma. Ann Thorac Surg (2011) 1.46
Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure. Int J Cardiol (2005) 1.43
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Lung Cancer (2006) 1.43
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group. J Clin Oncol (2004) 1.42
The molecular logic for planarian regeneration along the anterior-posterior axis. Nature (2013) 1.41
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg (2005) 1.41
Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis. Cancer Sci (2013) 1.39
Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol (2009) 1.38
Progressive leukoencephalopathy with intracranial calcification, congenital deafness, and developmental deterioration. Am J Med Genet A (2011) 1.38
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol (2008) 1.36
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology (2006) 1.31
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol (2007) 1.28
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer (2008) 1.27
Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates. Dev Neurobiol (2007) 1.22
Depressive patients are more impulsive and inconsistent in intertemporal choice behavior for monetary gain and loss than healthy subjects--an analysis based on Tsallis' statistics. Neuro Endocrinol Lett (2008) 1.21
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg (2003) 1.20
Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol (2009) 1.19
Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg (2004) 1.18
Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology (2006) 1.17
Epidermal inclusion cyst of the breast. Breast Cancer (2007) 1.17
A case of solid neuroendocrine carcinoma of the breast in a 40-year-old woman. Breast Cancer (2007) 1.17
Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo. Biochem Pharmacol (2002) 1.17
The novel Myb transcription factor LCR1 regulates the CO2-responsive gene Cah1, encoding a periplasmic carbonic anhydrase in Chlamydomonas reinhardtii. Plant Cell (2004) 1.15
Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr (2004) 1.13
Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol (2010) 1.13
Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.12
Origins of mouse inbred strains deduced from whole-genome scanning by polymorphic microsatellite loci. Mamm Genome (2005) 1.12
Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med (2009) 1.11
Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour. EMBO J (2009) 1.11
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clin Cancer Res (2002) 1.10
Photodynamic therapy for cervical intraepithelial neoplasia. Oncology (2005) 1.10
Predictive factors of lymph node metastasis in patients with undifferentiated early gastric cancers. J Clin Gastroenterol (2006) 1.08
Neocortical layer formation of human developing brains and lissencephalies: consideration of layer-specific marker expression. Cereb Cortex (2010) 1.08
RNA interference by feeding in vitro-synthesized double-stranded RNA to planarians: methodology and dynamics. Dev Dyn (2013) 1.07
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung Cancer (2012) 1.07
Relationship of thrombus characteristics to the incidence of angiographically visible distal embolization in patients with ST-segment elevation myocardial infarction treated with thrombus aspiration. JACC Cardiovasc Interv (2013) 1.07
Spontaneous regression of hepatocellular carcinoma: report of a case. Surg Today (2005) 1.06
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2012) 1.05
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Res Treat (2009) 1.05
CNOT2 depletion disrupts and inhibits the CCR4-NOT deadenylase complex and induces apoptotic cell death. Genes Cells (2011) 1.05
Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3beta and beta-catenin/TCF pathway. Neuropsychopharmacology (2008) 1.04
Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med (2008) 1.04
Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep (2010) 1.04
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol (2010) 1.04
Providing palliative care for cancer patients: the views and exposure of community general practitioners and district nurses in Japan. J Pain Symptom Manage (2011) 1.03
Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients. Hum Pathol (2004) 1.03
Preferred place of care and place of death of the general public and cancer patients in Japan. Support Care Cancer (2012) 1.03
Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol (2012) 1.02
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas (2013) 1.01
The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey. Ann Nucl Med (2012) 1.01
PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol (2005) 1.01
The N-terminal domain of MYO18A has an ATP-insensitive actin-binding site. Biochemistry (2005) 1.01
A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active EGFR mutations: Okayama Lung Cancer Study Group trial 0705. J Thorac Oncol (2010) 1.00
Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer (2008) 1.00
Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer. Anticancer Res (2010) 0.99
First impression at stroke onset plays an important role in early hospital arrival. Intern Med (2006) 0.99
Solitary fibrous tumor of the pancreas. Jpn J Radiol (2010) 0.99
Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J (2005) 0.99
Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer. Psychooncology (2008) 0.99
Multifocal fibrosclerosis combined with idiopathic retro-peritoneal and pericardial fibrosis. Intern Med (2006) 0.98
Modified primary sutureless repair of total anomalous pulmonary venous connection in heterotaxy. Ann Thorac Surg (2009) 0.97
Cap polyposis cured by Helicobacter pylori eradication therapy. J Gastroenterol (2002) 0.97
Nodular pseudoangiomatous stromal hyperplasia of mammary stroma in a case showing rapid tumor growth. Breast Cancer (2005) 0.96